Primary Sclerosing Cholangitis(PSC) is a chronic liver disease characterized by inflammation of the biliary epithelia progressively leading to fibrosis and biliary strictures formation and in the advanced disease to liver cirrhosis and cholangiocarcinoma occurrence. To date, PSC eziology is not fully understood leading to a lack in effective therapies able to reduce disease progression. The present review aims to discuss the current concepts about PSC pathogenesis and provides an updating of the therapeutical approaches against such chronic biliary disease.

Current targets for Primary Sclerosing cholangitis / Pierantonelli, Irene; Benedetti, Antonio; Marzioni, Marco. - In: CURRENT DRUG TARGETS. - ISSN 1873-5592. - (2016). [10.2174/1389450117666160112114152]

Current targets for Primary Sclerosing cholangitis

PIERANTONELLI, IRENE;BENEDETTI, Antonio;MARZIONI, MARCO
2016-01-01

Abstract

Primary Sclerosing Cholangitis(PSC) is a chronic liver disease characterized by inflammation of the biliary epithelia progressively leading to fibrosis and biliary strictures formation and in the advanced disease to liver cirrhosis and cholangiocarcinoma occurrence. To date, PSC eziology is not fully understood leading to a lack in effective therapies able to reduce disease progression. The present review aims to discuss the current concepts about PSC pathogenesis and provides an updating of the therapeutical approaches against such chronic biliary disease.
2016
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11566/248498
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact